当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 现金流量表

金陵药业

(000919)

  

流通市值:41.47亿  总市值:41.48亿
流通股本:6.22亿   总股本:6.22亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,438,635,530.181,723,540,942.37749,750,020.673,270,504,012.57
  收到的税费返还000642,060.75
  收到其他与经营活动有关的现金53,996,256.1630,510,544.6813,437,298.4528,320,009.93
  经营活动现金流入小计2,492,631,786.341,754,051,487.05763,187,319.123,299,466,083.25
  购买商品、接受劳务支付的现金1,140,608,631.25741,017,945.7375,637,414.761,628,792,195.61
  支付给职工以及为职工支付的现金902,124,292.33616,252,905.54323,516,968.081,164,775,088.69
  支付的各项税费95,078,996.7862,670,750.7728,475,389.35102,950,609.41
  支付其他与经营活动有关的现金117,753,896.2586,719,153.7536,605,306.62228,738,940.41
  经营活动现金流出小计2,255,565,816.611,506,660,755.76764,235,078.813,125,256,834.12
  经营活动产生的现金流量净额237,065,969.73247,390,731.29-1,047,759.69174,209,249.13
二、投资活动产生的现金流量:
  收回投资收到的现金675,528,446.38339,143,503.04127,295,075.71,146,410,563.81
  取得投资收益收到的现金5,907,339.985,646,467.381,988,519.9937,129,993.61
  处置固定资产、无形资产和其他长期资产收回的现金净额6,891,653.016,828,303.956,569,011120,522.01
  投资活动现金流入小计688,327,439.37351,618,274.37135,852,606.691,183,661,079.43
  购建固定资产、无形资产和其他长期资产支付的现金95,149,252.6847,235,571.479,574,584.72157,867,056.59
  投资支付的现金908,000,000635,018,060.98431,343,089.731,335,200,000
  投资活动现金流出小计1,003,149,252.68682,253,632.45440,917,674.451,493,067,056.59
  投资活动产生的现金流量净额-314,821,813.31-330,635,358.08-305,065,067.76-309,405,977.16
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金66,602,620.8665,485,613.581,558,501.477,729,031.64
  其中:子公司支付给少数股东的股利、利润1,727,251.41,727,251.4677,251.410,214,127.39
  支付其他与筹资活动有关的现金712,755.06712,755.0607,347,041.54
  筹资活动现金流出小计67,315,375.9266,198,368.641,558,501.485,076,073.18
  筹资活动产生的现金流量净额-67,315,375.92-66,198,368.64-1,558,501.4-85,076,073.18
四、汇率变动对现金及现金等价物的影响-62,943.32-32,399.24-6,356.948,450.56
五、现金及现金等价物净增加额-145,134,162.82-149,475,394.67-307,677,685.79-220,264,350.65
  加:期初现金及现金等价物余额1,361,103,616.771,361,103,616.771,361,103,616.771,581,367,967.42
  期末现金及现金等价物余额1,215,969,453.951,211,628,222.11,053,425,930.981,361,103,616.77
补充资料:
  净利润-55,979,155.13-51,292,285.96
  资产减值准备--3,723,683.97-8,748,466.31
  固定资产和投资性房地产折旧-56,156,018.93-134,621,180.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-56,156,018.93-134,621,180.99
  无形资产摊销-8,520,344.56-21,886,650.43
  长期待摊费用摊销-6,446,097.52-12,546,129.66
  处置固定资产、无形资产和其他长期资产的损失--4,830,130.71-387,493.74
  固定资产报废损失-301,177.17-912,072.1
  公允价值变动损失-4,972,798.5-108,568.42
  财务费用-2,503,500.85--4,063,493.49
  投资损失--8,312,706.54--30,195,899.89
  递延所得税--3,874,034.18--2,381,419.59
  其中:递延所得税资产减少--1,472,729.6--115,580
    递延所得税负债增加--2,401,304.58--2,265,839.59
  存货的减少-44,576,953.37-37,462,117.21
  经营性应收项目的减少-96,215,810.65-5,120,409.92
  经营性应付项目的增加--8,174,275.41--63,486,643.38
  其他----3,458,083.53
  现金的期末余额-1,211,628,222.1-1,361,103,616.77
  减:现金的期初余额-1,361,103,616.77-1,581,367,967.42
  现金及现金等价物的净增加额--149,475,394.67--220,264,350.65
公告日期2026-10-262026-08-292026-04-282026-03-31
审计意见(境内)标准无保留意见
TOP↑